Trinity Biotech (TRIB) EBITDA Margin (2009 - 2024)
Trinity Biotech's (TRIB) quarterly EBITDA Margin came in at 72.61% in Q4 2024, down 4446.0% year-on-year from 1.67% in Q1 2024, and down 330.07% quarter-over-quarter from 16.88% in Q3 2024.
Trinity Biotech (TRIB) EBITDA Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has disclosed EBITDA Margin across 16 years of filings, most recently posting 72.61% for Q4 2024.
- EBITDA Margin for Q4 2024 came in at 72.61%, down 4446.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 34.38% (up 1321.0% YoY), and the FY2025 annual result was 36.06%, down 168.0% from the prior year.
- EBITDA Margin came in at 72.61% for Q4 2024 at Trinity Biotech, down from 16.88% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 28.38% in Q3 2020 to a low of 106.86% in Q2 2023.
- The 5-year median for EBITDA Margin is 14.44% (2022), against an average of 17.79%.
- Across the five-year window, EBITDA Margin sank 9486 bps in 2023 and surged 8129 bps in 2024, its largest moves.
- Trinity Biotech's EBITDA Margin stood at 27.67% in 2020, then tumbled by 90 bps to 2.88% in 2021, then slumped by 1899 bps to 51.87% in 2022, then jumped by 46 bps to 28.14% in 2023, then sank by 158 bps to 72.61% in 2024.
- The last three EBITDA Margin figures came in at 72.61% (Q4 2024), 16.88% (Q3 2024), and 25.58% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -72.61% |
| Sep 30, 2024 | -16.88% |
| Jun 30, 2024 | -25.58% |
| Mar 31, 2024 | -20.68% |
| Dec 31, 2023 | -28.14% |
| Sep 30, 2023 | -30.66% |
| Jun 30, 2023 | -106.86% |
| Mar 31, 2023 | -26.43% |
| Dec 31, 2022 | -51.87% |
| Sep 30, 2022 | -51.78% |
| Jun 30, 2022 | -12.00% |
| Mar 31, 2022 | -7.76% |
| Dec 31, 2021 | 2.88% |
| Sep 30, 2021 | 12.58% |
| Jun 30, 2021 | 0.84% |
| Mar 31, 2021 | 12.03% |
| Dec 31, 2020 | 27.67% |
| Sep 30, 2020 | 28.38% |
| Jun 30, 2020 | 3.13% |
| Mar 31, 2020 | 7.99% |